Evidence map›Paper›PMID 35306683›Full record

ArticleJournal of clinical pharmacy and therapeutics2022

Implementation of a pharmacist-led transitional pharmaceutical care programme: Process evaluation of Medication Actions to Reduce hospital admissions through a collaboration between Community and Hospital pharmacists (MARCH).

Selma En-Nasery-de Heer, Elien B Uitvlugt, Pierre M Bet, Bart J F van den Bemt, Aida Alai, Patricia M L A van den Bemt, Eleonora L Swart, Fatma Karapinar-Çarkit, Jacqueline G Hugtenburg

Open access · hybridAbstract read
In one paragraph

Article in Journal of clinical pharmacy and therapeutics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.6field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Selma En-Nasery-de HeerDepartment of Clinical Pharmacology and Pharmacy, Amsterdam UMC, Amsterdam, The Netherlands.ORCID https://orcid.org/0000-0002-3212-7765
Elien B UitvlugtDepartment of Clinical Pharmacy, OLVG, Amsterdam, The Netherlands.
Pierre M BetDepartment of Clinical Pharmacology and Pharmacy, Amsterdam UMC, Amsterdam, The Netherlands.
Bart J F van den BemtDepartment of Pharmacy, Sint Maartenskliniek, Nijmegen, The Netherlands.
Aida AlaiDepartment of Clinical Pharmacology and Pharmacy, Amsterdam UMC, Amsterdam, The Netherlands.
Patricia M L A van den BemtDepartment of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, Groningen, The Netherlands.
Eleonora L SwartDepartment of Clinical Pharmacology and Pharmacy, Amsterdam UMC, Amsterdam, The Netherlands.
Fatma Karapinar-ÇarkitDepartment of Clinical Pharmacy, OLVG, Amsterdam, The Netherlands.
Jacqueline G HugtenburgDepartment of Clinical Pharmacology and Pharmacy, Amsterdam UMC, Amsterdam, The Netherlands.
Amsterdam Neuroscience · NLOLVG · NLRadboud University Nijmegen · NLUniversity Medical Center Groningen · NL

Funding

The Royal Dutch Pharmacists Association (Koninklijke Nederlandse Maatschappij ter bevordering der Pharmacie, KNMP)
6 · The paper itself

Abstract

WHAT IS KNOWN AND

objectiveThe recently conducted Medication Actions to Reduce hospital admissions through a collaboration between Community and Hospital pharmacists (MARCH) transitional care programme, which aimed to test the effectiveness of a transitional care programme on the occurrence of ADEs post-discharge, did not show a significant effect. To clarify whether this non-significant effect was due to poor implementation or due to ineffectiveness of the intervention as such, a process evaluation was conducted. The aim of the study was to gain more insight into the implementation fidelity of MARCH.

methodsA mixed methods design and the modified Conceptual Framework for Implementation Fidelity was used. For evaluation, the implementation fidelity and moderating factors of four key MARCH intervention components (teach-back, the pharmaceutical discharge letter, the post-discharge home-visit and the transitional medication review) were assessed. Quantitative data were collected during and after the intervention. Qualitative data were collected using semi-structured interviews with MARCH healthcare professionals (community pharmacists, clinical pharmacists, pharmacy assistants and pharmaceutical consultants) and analysed using thematic analysis. RESULTS AND DISCUSSION: Not all key intervention components were implemented as intended. Teach-back was not always performed. Moreover, 63% of the pharmaceutical discharge letters, 35% of the post-discharge home-visits and 44% of the transitional medication reviews were not conducted within their planned time frames. Training sessions, structured manuals and protocols with detailed descriptions facilitated implementation. Intervention complexity, time constraints and the multidisciplinary coordination were identified as barriers for the implementation. WHAT IS NEW AND

conclusionOverall, the implementation fidelity was considered to be moderate. Not all key intervention components were carried out as planned. Therefore, the non-significant results of the MARCH programme on ADEs may at least partly be explained by poor implementation of the programme. To successfully implement transitional care programmes, healthcare professionals require full integration of these programmes in the standard work-flow including IT improvements as well as compensation for the time investment.

Indexed as

Community Pharmacy ServicesPharmacyTransitional CareAftercareHospitalsHumansPatient DischargePharmaceutical PreparationsPharmacistsPharmaceutical Preparationsadverse eventclinical pharmacycommunity pharmacyimplementation fidelitymedicationmedicine useoutcome and process assessment (health care)patient counsellingpharmaceutical carepharmacist consultationpharmacistsprocess evaluationtransitional care

Identifiers

PMID35306683
PMCPMC9544789
OpenAlexW4220931782

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.